SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals
ARIA 23.990.0%Feb 17 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Lawrence Hilzenrath who wrote (41)2/19/1997 2:12:00 PM
From: Boyce Burge   of 4474
 
The news being.. that Ariad has done a deal with Genovo, a private concern in Philadelphia... it seems clear that they will jointly put together vectors for injection.... expression of which will subsequently be controlled by taking an oral drug. Also, its pretty clear they are trying to interest cos who already have a large molecule drug (like Amgen or Biogen or Genentech...) in signing up for partnerships.

It would be good to know more about the Genovo, its track record and technology.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News